• Home
  • About Us
  • Our People
  • Technology
  • News
  • Contact Us

QNBV Status Awarded to Pan Genome Systems

3/19/2014

0 Comments

 
Pan Genome Systems announced today that the company had recently received confirmation of its certification under Wisconsin's Qualified New Business Venture Program (QNBV) tax incentive program.

"This is a great program for encouraging Wisconsin businesses, and we are pleased to be part of it" said Pan Genome Systems President, Jon Sandbrook. "The program is certainly beneficial for both investors and early stage companies, and it helps companies like ours to secure the support we need to be successful" he said.

Wisconsin’s Early Stage Business Investment Program and Qualified New Business Venture Program (QNBV) work together to spur investment in early stage Wisconsin businesses with the potential for significant economic impact and job growth. The programs are simple and effective, creating mutually beneficial outcomes for investors, businesses and Wisconsin’s economy.

How It Works
Early stage businesses developing innovative products, processes or services may be designated as QNBVs. Investments in QNBVs made by angel investors, angel investment networks and qualified venture capital funds are eligible to receive a tax credit equal to 25 percent of the amount of the equity investment through the Early Stage Business Investment Program.
0 Comments
 

    Archives

    October 2014
    September 2014
    August 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013

    RSS Feed


Home
About Us
Technology
Products
Contact Us
Email: info@pangenosys.com
Phone: (608) 441 2834
Web: www.pangenosys.com
Picture
-----     Pan Genome Systems Inc - The Next Generation in Vaccines     |     © Pan Genome Systems Inc.     505 S. Rosa Rd, Suite 20B, Madison, WI 53719     +1 (608) 441 2834     info@pangenosys.com     ----